Improved adherence with once-daily versus twice-daily dosing of mometasone furoate administered via a dry powder inhaler: a randomized open-label study

Lignende værker

• Long-term safety of Mometasone Furoate administered via a dry powder inhaler in children: Results of an open-label study comparing Mometasone Furoate with Beclomethasone Dipropionate in children with persistent asthma
  af: Noonan, Michael, et al.
  Udgivet: (2009)
• Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
  af: Kosoglou T, et al.
  Udgivet: (2013-03-01)
• Comparison of the systemic bioavailability of mometasone furoate after oral inhalation from a mometasone furoate/formoterol fumarate metered-dose inhaler versus a mometasone furoate dry-powder inhaler in patients with chronic obstructive pulmonary disease
  af: Kosoglou, Teddy, et al.
  Udgivet: (2013)
• Is once enough? Understanding the preferences of COPD and asthma patients for once- versus twice-daily treatment
  af: Horne, Rob
  Udgivet: (2013)
• Fluticasone furoate: once-daily evening treatment versus twice-daily treatment in moderate asthma
  af: Woodcock Ashley, et al.
  Udgivet: (2011-12-01)